by Mihai | Aug 22, 2023 | Uncategorized
Advanced NanoTherapies (ANT) Secures $4M Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD) Milestone achieved as company announces successful enrollment of ten patients...
by Alexandra | Sep 19, 2022 | Uncategorized
Advanced NanoTherapies’ SirPlux Duo Drug-Coated Balloon Receives FDA Breakthrough Designation for Small Vessel Coronary Artery Disease Breakthrough Designation Reinforces Significant Unmet Need in Treatment of Small Vessel Coronary Arteries LOS GATOS, CA – September...
by Mihai | Jun 28, 2022 | Uncategorized
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing Funds to support the first-in-human clinical study of the company’s SirPluxTM Duo Drug-Coated Balloon for the treatment of de-novo coronary artery disease LOS GATOS, CA – June...
by Dora | Jan 10, 2022 | Uncategorized
SirPlux Duo Receives Breakthrough Designation On May 28, 2021, the US Food and Drug Administration (FDA) granted Advanced NanoTherapies Breakthrough Designation for its SirPlux Duo device. SirPlux Duo is a drug-coated balloon (DCB) that leverages nanotechnology to...
by Mihai | Oct 13, 2020 | Uncategorized
Advanced NanoTherapies Raises $5.3 Million in Seed-Round Company accelerates development of its nanoparticle-based drug delivery technology platform to treat peripheral artery disease and other applications LOS GATOS, Calif. – October 13, 2020 – Advanced...
